Sharmila Dissanaike
Board Member
Heron Therapeutics, Inc. /De/ (HRTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Sharmila Dissanaike
Sharmila Dissanaike is recorded as Board Member at Heron Therapeutics, Inc. /De/ (HRTX). Heron Therapeutics, Inc. /De/ reported in an 8-K filed June 18, 2024 that Sharmila Dissanaike was appointed Director, effective June 13, 2024.
“to elect six director nominees: Craig Collard, Sharmila Dissanaike, M.D., FACS, FCCM, Craig Johnson, Susan Rodriguez, Christian Waage, and Adam Morgan, to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Heron Therapeutics, Inc. /De/
Other people whose current roles at this company are on record from its filings.
- Craig Collard CEO, Board Member
- Adam Morgan Chairman, Board Member
- Ira Duarte CFO, Chief Accounting Officer
- Mark Hensley COO
- Lisa Peraza Chief Accounting Officer
- Christian Waage Board Member
- Craig Johnson Board Member
- Kevin Kotler Board Member
- Michael Kaseta Board Member
- Sharmila Dissanaike, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.